Studies suggest that most of the point mutations are extremely rare and not likely to contribute any major role in PD pathogenesis although parkin mutations are quite prevalent in early onset of PD [71,172,173] and LRRK2 mutations contribute to cause 2% of the sporadic aspects of PD [174,175]. This evidence concerns the gene PRKN and Parkinson disease.